On the Move Systems Corp.
On the Move Systems Corp.
- ISIN: US68220L2034
- Land: .
Nachricht vom 20.04.2017 | 15:29
OMVS Enters into Advanced Discussions with Robotic Assistance Devices
DGAP-News: On the Move Systems Corp. / Key word(s): Miscellaneous
Henderson, Nevada--(Newsfile Corp. - April 20, 2017) - On the Move Systems (OTC Pink: OMVS) is pleased to announce that it has entered into advanced discussions with Robotic Assistance Devices (RAD) www.roboticassistancedevices.com for a potential strategic transaction. RAD is specialized in the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs. RAD is initially targeting the security industry which uses electronic systems and approximately 1.1 million security guards in the US. The RAD robot security guard solution combines the best of both solutions to provide superior security at a price that provides clients immediate ROI.
RAD's robotic unit is a fully autonomous unmanned ground vehicle that can perform 80% of the tasks of a human security guard at less than half the cost. It incorporates advanced intelligence to augment traditional patrolling services by detecting humans and vehicles and initiating the standard operating procedures much like a human security guard. It operates up to 12 hours without recharging and continuously patrols in any weather environment, including rain, snow, gusty wind, and temperatures ranging from -10° F to 125° F. The security robot incorporates automatic obstacle avoidance sensors, two-way audio, panic button and on-board 360 degree video surveillance to create situational awareness much greater than any other type of solution. It integrates with leading video management solutions and supports other business systems for special equipment, sensor integration and advanced software development. Data is captured and stored in the cloud for long-term data and video retention.
RAD currently has a sales pipeline of over 50 Fortune 500 companies and over 25 qualified dealers and distributors that have a combined customer base of more than 35,000 end user corporations.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
This release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are 'forward-looking statements' that are based on current expectations and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the statements, including, but not limited to, the following: the ability of On the Move Systems to provide for its obligations, to provide working capital needs from operating revenues, to obtain additional financing needed for any future acquisitions, to meet competitive challenges and technological changes, and other risks. On the Move Systems undertakes no duty to update any forward-looking statement(s) and/or to confirm the statement(s) to actual results or changes in On the Move Systems expectations.
Public Relations and Media Contact:
Everest Corporate Advisors Inc.
Click on, or paste the following link into your web browser, to view the associated documents http://www.newsfilecorp.com/release/26257
|Company:||On the Move Systems Corp.|
|End of News||DGAP News Service|
GBC im Fokus
23. MKK – Münchner Kapitalmarkt Konferenz
Für: Institutionelle Investoren & Presse
Wann: 26. & 27. April 2017, 9 - 17 Uhr
Wo: The Charles Hotel - Rocco Forte Hotels, München
GBC im Fokus
Neovacs S.A.: Kursziel auf 3,30 € angehoben
In den letzten Monaten hatte die Neovacs S.A. einen positiven Newsflow. Im Vordergrund steht die Vertriebspartnerschaft für den chinesischen Markt, wodurch sich bis nach dem ersten Vermarktungsjahr Gesamterträge von bis zu 65 Mio. € ergeben können. Zudem verläuft der klinische Zulassungsprozess des IFNα-Kinoid zur Behandlung von SLE (Systemischer Lupus) und Dermatomyositis planmäßig. Wir haben in unsere Bewertung aktualisiert und ein Kursziel von 3,30 € je Aktie (bisher: 2,90 €) ermittelt. Das Rating lautet weiter KAUFEN.
Der AKTIONÄR News
25. April 16:29 Biotech-Sektor: Starke Biogen-Zahlen treiben an
25. April 16:15 Netflix erobert China durch die Hintertür – Aktie wieder auf ...
25. April 15:11 Innogy: Keine Panik!
25. April 13:44 Bußlers Geheimtipps: … jetzt erst einmal die Korrektur
News im Fokus
Continental startklar: Nächster Wachstumsschub durch innovative Antriebstechnologien
25. April 2017, 08:30
Q1 Results 2017
10. Mai 2017
Original-Research: Ludwig Beck AG (von Montega AG): Kaufen
25. April 2017